PATENT CLAIM ANALYSIS

Application Number: 16297398
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "637000"]

Abstract:
The present invention relates to pyrrolidone carboxylic acid (PCA) and/or pharmaceutically acceptable salts or derivatives thereof for use in the treatment of ocular diseases and/or disorders. A further object of the present invention are compositions comprising pyrrolidone carboxylic acid (PCA) and/or pharmaceutically acceptable salts or derivatives thereof, at least one physiologically acceptable excipient, and optionally at least one additional active ingredient for use in the treatment of ocular diseases and/or disorders.

Claim (Index 1):
A method for treating ocular diseases and/or disorders in a subject, comprising administering to a subject (i) pyrrolidone carboxylic acid and/or a pharmaceutically acceptable salt thereof, and (ii) one or more active ingredient selected from the group consisting of a metal salt, hyaluronic acid, a cellulose derivative, an osmoprotectant, and a mixture thereof, wherein (i) and (ii) are the only active ingredients administered to the subject.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 99.0
- Lexical Diversity: 1.75556
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15558524', '15555527', '11123436', '16042003', '14211427']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6659950502138188
- 35 USC 102 Novelty (BERT): 0.512750784248853
- Combined Prediction Score: 0.6506706236173222
- Mean Citation Score: 208.853702
- Max Citation Score: 298.81458
- Similarity Product: 257.03039532714484

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test